Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.2 (
topoisomerase
)
9,166
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present work, we show that the activity of DNA topoisomerase II in quail oviduct nuclei significantly increases with age. Posttranslational modifications of the nuclear-matrix-associated enzyme by matrix-bound
poly(ADP-ribose) synthetase
and protein kinase, whose activities change with age, are demonstrated and offer possible mechanisms by which the age-dependent change in enzyme activity may be caused. It is assumed that the age-correlated enhancement of DNA-
topoisomerase
-II activity may cause changes in the topological state of DNA, with possible consequences for DNA replication, transcription, and repair with age.
...
PMID:[Age-related changes in the activity and post-translational modification of DNA topoisomerase II in the quail oviduct]. 216 9
Nuclear DNA topoisomerase II activity in quail oviduct tissue was found to increase by about 70% with age. This age-dependent increase was observed with both the enzyme in whole nuclear extract and nuclear matrix-associated
topoisomerase
II. Both purified
topoisomerase
II and the nuclear matrix-bound enzyme were found to be modifiable by phosphorylation and poly(ADP-ribosyl)ation. Phosphorylation of the purified enzyme by isolated nuclear protein kinase NII or protein kinase C resulted in a 2- to 3-fold increase in specific activity, while poly(ADP-ribosyl)ation by soluble
poly(ADP-ribose) synthetase
caused a 50% inhibition of the enzyme. Using immunoprecipitation and immunoblotting procedures, phosphorylation and poly(ADP-ribosyl)ation could also be demonstrated to occur with the nuclear matrix-associated enzyme. The nuclear matrix-associated NII-like protein kinase activity, assumed to be involved in post-translational modification of
topoisomerase
II, displayed a 1.4- to 1.6-fold increase in old animals compared to mature ones, while the matrix-bound
poly(ADP-ribose) synthetase
activity decreased by about 50%. It is suggested that age-correlated enhancement of DNA topoisomerase II activity, possibly due to age-dependent changes in activities of nuclear protein kinases and
poly(ADP-ribose) synthetase
, may result in alterations in the topological state of DNA, possibly affecting DNA replication, transcription and repair with age.
...
PMID:Age-dependent increase of DNA topoisomerase II activity in quail oviduct; modulation of the nuclear matrix-associated enzyme activity by protein phosphorylation and poly(ADP-ribosyl)ation. 255 26
A
DNA topoisomerase
activity, copurifying with
poly(ADP-ribose) synthetase
from calf thymus, is greater than 95% inhibited if extensive poly(ADP-ribosylation) is allowed to occur. The inhibited
DNA topoisomerase
, which has drastically different elution properties on hydroxylapatite, can be reactivated by mild alkaline treatment. These results are consistent with a poly(ADP-ribosylation) of the
DNA topoisomerase
and covalent attachment of the poly(ADP-ribose) moieties to the
topoisomerase
by alkali-labile bonds.
...
PMID:Poly(ADP-ribosylation) of a DNA topoisomerase. 630 23
We demonstrate that the activity of the major DNA topoisomerase I from calf thymus is severely inhibited after modification by purified
poly(ADP-ribose) synthetase
. Polymeric chains of poly(ADP-ribose) are covalently attached to DNA topoisomerase I. These observations with highly purified enzymes suggest that poly(ADP-ribosylation) may be a cellular mechanism for modulating DNA topoisomerase I activity in response to the state of DNA in the nucleus. Although extensive poly(ADP-ribosylation) of the Mr = 100,000 DNA topoisomerase I from calf thymus resulted in greater than 90% enzyme inhibition, exogenous poly(ADP-ribose) does not, by itself, inhibit
topoisomerase
activity. After modification, the apparent molecular weight of both the
topoisomerase
enzyme protein and of the
topoisomerase
enzyme activity was increased. In vitro, the extent of modification of DNA topoisomerase I could be controlled either by changing the ratio of
topoisomerase
to the synthetase or by varying the reaction time. More than 40 residues of ADP ribose per
topoisomerase
molecule could be added by the synthetase. Analysis of a poly(ADP-ribosylated)
topoisomerase
preparation that was about 50% inhibited revealed an average polymer chain length of 7.4, with 1-2 chains per enzyme molecule.
...
PMID:Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. 632 15